Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 27 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

2 trials in Phase 3/4

Results Transparency

0 of 14 completed trials have results

Key Signals

4 recruiting

Enrollment Performance

Analytics

N/A

18(90.0%)

Phase 3

1(5.0%)

Phase 4

1(5.0%)

20Total

N/A(18)

Phase 3(1)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (27)

Showing 20 of 27 trials

NCT07302932Not ApplicableCompleted

Metformin and Molecular Aging in Prediabetes

Role: lead

NCT07205705Not ApplicableNot Yet Recruiting

Impact of Partially Replacing Wheat With Millets or Bengal Gram Flour in Rotis on Glycemia and Prediabetes Reversal

Role: lead

NCT06454773Phase 3Recruiting

To Evaluate the Impact of Consumption of Bioactive Compounds Extracted From Hemp Hull and Black Pepper on Fasting Blood Glucose Levels in People With Pre-diabetes: A Randomized Placebo-Controlled Parallel Arm Trial

Role: lead

NCT06386939Recruiting

Comparison of Micro- and Macrovascular Disease(s) in People With T2D, Who Have Moderate to Severe Acanthosis Nigricans vs. Those Who do Not Have Acanthosis Nigricans

Role: lead

NCT06386952Recruiting

To Compare People With T2DM Who Have Double Hump Versus Who do Not Have Double Hump

Role: lead

NCT05939895Recruiting

To Identify Anytime Hyperglycaemia in Subjects With Normoglycaemia and Prediabetes

Role: lead

NCT06055582Not ApplicableCompleted

To Study the Effects of Mango Ingestion in T2DM and Non-diabetic Subjects.

Role: lead

NCT05939921Not ApplicableCompleted

Effects of Metformin Therapy on Pancreatic and Hepatic Fat Content in Patients of Type 2 Diabetes Mellitus